InsiderTrades

Form 4 for AP AMPCO PITTSBURGH CORP

Accepted 2023-05-24 00:00:00 ET · period of report 2020-09-22 · accession 0001209191-23-031817 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2023-05-24 2022-07-22 AP PFORZHEIMER CARL H II Dir M - OptEx $4.00 +714 3,028 +31% +$2,856
DI 2023-05-24 2020-09-22 AP PFORZHEIMER CARL H II Dir X - OptEx $3.50 +714 2,314 +45% +$2,499
DI 2023-05-24 2022-07-22 AP PFORZHEIMER CARL H II Dir M - OptEx — -1,600 0 -100% —
DMI 2023-05-24 2020-09-22 AP PFORZHEIMER CARL H II Dir X - OptEx $0.00 0 1,600 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-07-22 M A 714 $4.00 3,028 I See Footnote — — (F1) This Form 4 is being filed to include the acquisition of shares of common stock and Series A Warrants that had been inadvertently omitted. (F4) Represents the conversion of Series A warrants issued by the Issuer as part of the Rights Offering, converted at the temporarily discounted price of $1.7856 per Series A warrant (or $4.00 per whole share of the Issuer's common stock). Beginning May 31, 2022 and expiring at 11:59 p.m. Eastern Time on July 15, 2022, the Issuer through an offer to exercise offered holders of the Issuer's outstanding Series A warrants the opportunity to exercise their Series A warrants at the temporarily reduced exercise price of $1.7856 per Series A warrant (or $4.00 per whole share of the Corporation's common stock). (F3) Shares are held equally between two different trusts, including half of the shares that are held by a trust of which Reporting Person is a trustee and principal beneficiary and the other half are held by a trust of which Reporting Person is a trustee in which he disclaims beneficial ownership.
2 Common Common Stock 2020-09-22 X A 714 $3.50 2,314 I See Footnote — — (F1) This Form 4 is being filed to include the acquisition of shares of common stock and Series A Warrants that had been inadvertently omitted. (F3) Shares are held equally between two different trusts, including half of the shares that are held by a trust of which Reporting Person is a trustee and principal beneficiary and the other half are held by a trust of which Reporting Person is a trustee in which he disclaims beneficial ownership.
3 Derivative Series A Warrant (right to buy) 2022-07-22 M D 1,600 — 0 I See Footnote $2.57 · 2020-09-22 to 2025-08-01 714 Common Stock (F5) Other than between May 31, 2022 and before 11:59 p.m. Eastern Time on July 15, 2022, when each Series A warrant represented the right to purchase 0.4464 shares of common stock at a temporarily reduced exercise price of $1.7856 per each Series A warrant, each Series A warrant represents the right to purchase 0.4464 shares of common stock at an exercise price of $2.5668 per series A warrant (or $5.75 per whole share of the Issuer's common stock). The Series A warrants are exercisable only for whole numbers of shares of Common Stock. (F1) This Form 4 is being filed to include the acquisition of shares of common stock and Series A Warrants that had been inadvertently omitted. (F6) Series A warrants were issued on September 22, 2020 upon the conversion of a subscription right issued by the Issuer as part of a rights offering. Each subscription right was exercisable for units that consisted of (i) 0.4464 shares of common stock and (ii) a Series A warrant exercisable to acquire 0.4464 shares of common stock at an exercise price of $2.5668 (or $5.75 per whole share of common stock under the Series A warrants). The subscription price of each unit was $1.5624 per unit (or $3.50 per whole share of common stock and Series A warrants to purchase a whole share of common stock). The securities issued upon conversion of the subscription rights are exempted from Section 16(b) pursuant to Rule 16b-3. (F3) Shares are held equally between two different trusts, including half of the shares that are held by a trust of which Reporting Person is a trustee and principal beneficiary and the other half are held by a trust of which Reporting Person is a trustee in which he disclaims beneficial ownership.
4 Derivative Subscription Rights (right to buy) 2020-09-22 X D 1,600 $0.00 0 I See Footnote $1.56 · 2020-08-18 to 2020-09-18 — Units consisting of Common Stock and Series A Warrants (F1) This Form 4 is being filed to include the acquisition of shares of common stock and Series A Warrants that had been inadvertently omitted. (F3) Shares are held equally between two different trusts, including half of the shares that are held by a trust of which Reporting Person is a trustee and principal beneficiary and the other half are held by a trust of which Reporting Person is a trustee in which he disclaims beneficial ownership.
5 Derivative Series A Warrant (right to buy) 2020-09-22 X A 1,600 — 1,600 I See Footnote $2.57 · 2020-09-22 to 2025-08-01 714 Common Stock (F5) Other than between May 31, 2022 and before 11:59 p.m. Eastern Time on July 15, 2022, when each Series A warrant represented the right to purchase 0.4464 shares of common stock at a temporarily reduced exercise price of $1.7856 per each Series A warrant, each Series A warrant represents the right to purchase 0.4464 shares of common stock at an exercise price of $2.5668 per series A warrant (or $5.75 per whole share of the Issuer's common stock). The Series A warrants are exercisable only for whole numbers of shares of Common Stock. (F1) This Form 4 is being filed to include the acquisition of shares of common stock and Series A Warrants that had been inadvertently omitted. (F2) Represents the conversion of a subscription right issued by the Issuer as part of a rights offering that closed on September 22, 2020 (the "Rights Offering"). Each subscription right was exercisable for units that consisted of (i) 0.4464 shares of common stock and (ii) a Series A warrant exercisable to acquire 0.4464 shares of common stock at an exercise price of $2.5668 (or $5.75 per whole share of common stock under the Series A warrants). The subscription price of each unit was $1.5624 per unit (or $3.50 per whole share of common stock and Series A warrants to purchase a whole share of common stock). The securities issued upon conversion of the subscription rights are exempted from Section 16(b) pursuant to Rule 16b-3. (F3) Shares are held equally between two different trusts, including half of the shares that are held by a trust of which Reporting Person is a trustee and principal beneficiary and the other half are held by a trust of which Reporting Person is a trustee in which he disclaims beneficial ownership.